Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) shed new light on triple‐negative breast cancer (TNBC), but only a minority of patients demonstrate response. Therefore, adaptive immune resistance (AIR) needs to be further defined to guide the development of ICI regimens. METHODS: Databases, includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xin‐Yu, Li, Bin, Wang, Ye, Jin, Juan, Yang, Yu, Huang, Lei‐Huan, Yang, Meng‐Di, Zhang, Jian, Wang, Bi‐Yun, Shao, Zhi‐Ming, Ni, Ting, Huang, Sheng‐Lin, Hu, Xi‐Chun, Tao, Zhong‐Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508140/
https://www.ncbi.nlm.nih.gov/pubmed/37434394
http://dx.doi.org/10.1002/cac2.12465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508140/
https://www.ncbi.nlm.nih.gov/pubmed/37434394
http://dx.doi.org/10.1002/cac2.12465

Ejemplares similares